SCI
TMO icon

Stableford Capital II’s Thermo Fisher Scientific TMO Stock Holding History

Stableford Capital II’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,664
Closed -$1.31M – 160
2026
Q1 		$1.31M Buy
2,664
+19
+0.7% +$10.3K 0.49% 55
2025
Q4 		$1.53M Sell
2,645
-121
-4% -$68.4K 0.55% 54
2025
Q3 		$1.34M Buy
2,766
+9
+0.3% +$4.19K 0.48% 53
2025
Q2 		$1.32M Buy
2,757
+1,642
+147% +$687K 0.5% 44
2025
Q1 		$477K Buy
1,115
+1
+0.1% +$542 0.2% 94
2024
Q4 		$580K Sell
1,114
-11
-1% -$6.05K 0.23% 103
2024
Q3 		$672K Sell
1,125
-5
-0.4% -$2.96K 0.27% 104
2024
Q2 		$627K Sell
1,130
-5
-0.4% -$2.86K 0.25% 104
2024
Q1 		$660K Buy
1,135
+2
+0.2% +$1.12K 0.26% 99
2023
Q4 		$619K Buy
+1,133
New +$548K 0.27% 93
2022
Q1 		– Sell
-1,415
Closed -$815K – 134
2021
Q4 		$815K Buy
1,415
+585
+70% +$365K 0.34% 85
2021
Q3 		$479K Buy
+830
New +$456K 0.24% 94
2020
Q2 		– Sell
-5,094
Closed -$1.45M – 79
2020
Q1 		$1.45M Buy
5,094
+1,640
+47% +$517K 1% 38
2019
Q4 		$1.12M Sell
3,454
-39
-1% -$11.8K 1.02% 29
2019
Q3 		$1.02M Sell
3,493
-156
-4% -$44.7K 0.95% 27
2019
Q2 		$1.07M Sell
3,649
-581
-14% -$160K 1.04% 25
2019
Q1 		$1.16M Sell
4,230
-339
-7% -$84.4K 0.96% 31
2018
Q4 		$1.02M Sell
4,569
-557
-11% -$131K 1.09% 29
2018
Q3 		$1.25M Buy
+5,126
New +$1.18M 0.83% 32
2017
Q2 		– Sell
-2,885
Closed -$443K – 122
2017
Q1 		$443K Buy
+2,885
New +$441K 0.38% 64

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Stableford Capital II's TMO Position: Q2 2026 in Review

Stableford Capital II sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 2,664 shares — an estimated $1.31M sold.

Stableford Capital II first reported a position in TMO in Q1 2017 and held it in 20 quarters. The position peaked at $1.53M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Stableford Capital II reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Stableford Capital II sold 2,664 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.31M.
  • Stableford Capital II first reported a position in Thermo Fisher Scientific in Q1 2017 and held it in 20 quarters.
  • Stableford Capital II's Thermo Fisher Scientific position peaked at $1.53M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Stableford Capital II's 13F filing for Q2 2026, filed 6 Jul 2026.